About EnteraSense
EnteraSense is a company based in Galway (Ireland) founded in 2016.. EnteraSense has raised $1.14 million across 3 funding rounds from investors including European Commission and European Union. EnteraSense operates in a competitive market with competitors including Prometheus Laboratories, Viome Life Sciences, NinePoint Medical, InDex Pharmaceuticals and Given Imaging, among others.
- Headquarter Galway, Ireland
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.14 M (USD)
in 3 rounds
-
Latest Funding Round
$2.85 M (USD), Grant
Jan 07, 2019
-
Investors
European Commission
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of EnteraSense
EnteraSense has successfully raised a total of $1.14M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $2.85 million completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $2.8M
-
First Round
First Round
(01 Jan 2019)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2019 | Amount | Seed - EnteraSense | Valuation |
investors |
|
| Jan, 2019 | Amount | Grant - EnteraSense | Valuation |
investors |
|
| Jan, 2019 | Amount | Grant - EnteraSense | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in EnteraSense
EnteraSense has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Commission and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Institution of the European Union responsible for upholding the EU treaties
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by EnteraSense
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - EnteraSense
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Enterasense Comparisons
Competitors of EnteraSense
EnteraSense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prometheus Laboratories, Viome Life Sciences, NinePoint Medical, InDex Pharmaceuticals and Given Imaging, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Diagnostics and therapeutics for gastrointestinal and personalized medicine are developed.
|
|
| domain | founded_year | HQ Location |
Provider of tests to prevent, treat, and cure chronic diseases, and cancer
|
|
| domain | founded_year | HQ Location |
Optical coherence tomography systems for tissue microstructure imaging are developed.
|
|
| domain | founded_year | HQ Location |
DNA-based immunomodulatory drugs for ulcerative colitis are developed.
|
|
| domain | founded_year | HQ Location |
Capsule endoscopy systems for GI imaging
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Enterasense
Frequently Asked Questions about EnteraSense
When was EnteraSense founded?
EnteraSense was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Where is EnteraSense located?
EnteraSense is headquartered in Galway, Ireland.
Is EnteraSense a funded company?
EnteraSense is a funded company, having raised a total of $1.14M across 3 funding rounds to date. The company's 1st funding round was a Grant of $1.18M, raised on Jan 01, 2019.
What does EnteraSense do?
Enterasense develops ingestible biosensors for GI disease. Its flagship product Sentinel is a sensor that is embedded in a capsule which is swallowed by the patient. The sensor then wirelessly transmits data to an accompanying app for the detection of bleeds in the upper GI tract.
Who are the top competitors of EnteraSense?
EnteraSense's top competitors include Viome Life Sciences, Prometheus Laboratories and NinePoint Medical.
Who are EnteraSense's investors?
EnteraSense has 2 investors. Key investors include European Commission, and European Union.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.